Gene Therapy Approaches to Replace or Restore Dystrophin PF-06939926 – Kasia Lobello, MD (Pfizer, Inc.) RGX-202 – Jahannaz Dastgir, DO (REGENXBIO) scAAV9.U7-ACCA – Kevin Flanigan, MD (Nationwide Children’s Hospital) SGT-001 – Carl Morris, PhD (Solid Biosciences) SRP-9001 – Teji Singh, MD (Sarepta Therapeutics) 2022 PPMD Annual Conference,Conferences & Meetings 2 years ago You may also like 1:07:15 DPT Meeting: Panel 2 – Endpoints & Schedule of Events 5 years ago 2019 Duchenne Platform Trial Stakeholder Meeting,Conferences & Meetings 44:50 DPT Meeting: Panel 3 – Operations & Governance 5 years ago 2019 Duchenne Platform Trial Stakeholder Meeting,Conferences & Meetings 1:02:36 DPT Meeting: Parent Commentary & Advocacy Perspective 5 years ago 2019 Duchenne Platform Trial Stakeholder Meeting,Conferences & Meetings 18:59 DPT Meeting: Key Takeaways & Next Steps 5 years ago 2019 Duchenne Platform Trial Stakeholder Meeting,Conferences & Meetings 1:22:00 Understanding Duchenne From The Start 5 years ago 2019 PPMD Annual Conference,Conferences & Meetings 1:09:37 Understanding Duchenne Behavioral Challenges (PPMD 2019 Conference) 5 years ago 2019 PPMD Annual Conference,Conferences & Meetings 19:21 Where Have We Come From & Where are We Going? (PPMD 2019 Conference) 5 years ago 2019 PPMD Annual Conference,Conferences & Meetings 1:31:49 The Complexities of Duchenne (PPMD 2019 Conference) 5 years ago 2019 PPMD Annual Conference,Conferences & Meetings «1…2122232425»Page 23 of 25
by: Parent Project Muscular Dystrophy
